FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities

J Am Geriatr Soc. 2012 Apr;60(4):684-90. doi: 10.1111/j.1532-5415.2011.03884.x. Epub 2012 Feb 8.

Abstract

Objectives: To examine screening strategies for osteoporosis and fractures for treatment of long-term care residents.

Design: Cross-sectional analysis to examine screening strategies for treatment.

Setting: Assisted living and skilled care facilities.

Participants: Two hundred two frail women aged 65 and older (mean 85), excluding those receiving bisphosphonates.

Measurements: Clinical fractures of the hip or spine (Clin Fx); Clin Fx or bone mineral density (BMD); Clin Fx, BMD, or vertebral fractures (VF) assessed according to dual-energy X-ray absorptiometry-based vertebral fracture assessments; fracture risk algorithm using femoral neck BMD (FRAX-FN); fracture risk algorithm using body mass index (FRAX-BMI); or Clin Fx or heel ultrasound (heel US).

Results: Treatment eligibility ranged from 17% (Clin Fx) to 98% (FRAX-BMI). VFs were found in 47%, 74% of which were silent. Criteria with Clin Fx, BMD, or VF identified 73% of study participants for treatment. FRAX-FN suggested treatment in 81% but would have missed approximately 10% of individuals with silent VFs. Clin Fx or heel US suggested that 39% of participants were eligible for treatment.

Conclusion: Long-term care residents eligible for osteoporosis treatment ranged from fewer than 20% to roughly all residents depending on screening criteria. VFs are common and identify a subset of residents missed by conventional BMD scans or FRAX-FN. A reasonable clinical approach could consider treatment for those with Clin Fx of the hip or spine, radiological evidence of a VF, or osteoporosis according to BMD classification. Prospective studies are needed to determine optimal screening strategies for treatment in this cohort.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorptiometry, Photon
  • Aged
  • Aged, 80 and over
  • Body Mass Index
  • Bone Density
  • Bone Density Conservation Agents / therapeutic use
  • Cross-Sectional Studies
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Incidence
  • Long-Term Care*
  • Mass Screening / methods*
  • Osteoporosis / diagnosis
  • Osteoporosis / drug therapy
  • Osteoporosis / epidemiology*
  • Osteoporotic Fractures / diagnosis
  • Osteoporotic Fractures / epidemiology*
  • Osteoporotic Fractures / prevention & control
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • United States / epidemiology

Substances

  • Bone Density Conservation Agents
  • Diphosphonates